Abstract
OBJECTIVE: To characterize the influence of Gelofusine (succinylated gelatin) on the performance of point-of-care testing (POCT) for human chorionic gonadotropin (hCG) devices. DESIGN AND METHODS: Three brands of urine and urine/serum hCG POCT devices were verified. RESULTS: Succinylated gelatin affected the performance of the control band in the QuickVue hCG POCT devices. Alternative devices were not affected. The hCG test performance is not influenced. CONCLUSIONS: Gelofusine affects specifically the quality control performance of the QuickVue hCG POCT devices.
Original language | English |
---|---|
Pages (from-to) | 1371-1372 |
Number of pages | 2 |
Journal | Clinical Biochemistry |
Volume | 43 |
Issue number | 16-17 |
DOIs | |
Publication status | Published - Nov 2010 |
Keywords
- Pregnancy test
- Point-of-care
- hCG urine
- Gelofusine
- Quality control
- PREGNANCY
- HCG